The FDA involves Rybelsus to hold a black box warning—one of the most major sort of warning—about the chance of thyroid C-mobile tumors. This warning stems from animal studies displaying that semaglutide and similar prescription drugs prompted thyroid tumors, such as most cancers, in rodents.